Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
MRK
|
Robert M Davis
Chairman, CEO & President |
SELL
Open market or private sale
|
Direct | 251,273 Reduced 59.5% |
$20,360,651
$81.03 p/Share
|
Oct 05
2020 |
MRK
|
Robert M Davis
Chairman, CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct | 251,273 Added 37.3% |
-
|
Oct 05
2020 |
ACN
|
Richard P Clark
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 95 Added 0.9% |
$21,232
$223.49 p/Share
|
Oct 05
2020 |
ACN
|
James O Etheredge
Chief Exec-North America |
BUY
Grant, award, or other acquisition
|
Direct | 109 Added 0.76% |
$24,360
$223.49 p/Share
|
Oct 05
2020 |
ACN
|
Kathleen R Mc Clure
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 109 Added 0.53% |
$24,360
$223.49 p/Share
|
Oct 05
2020 |
ACN
|
Jean Marc Ollagnier
CEO EMEA |
BUY
Grant, award, or other acquisition
|
Direct | 59 Added 0.03% |
$13,186
$223.49 p/Share
|
Oct 05
2020 |
ACN
|
Ellyn Shook
Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 109 Added 0.59% |
$24,360
$223.49 p/Share
|
Oct 05
2020 |
ACN
|
Julie Spellman Sweet
Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 140 Added 1.3% |
$31,289
$223.49 p/Share
|
Oct 05
2020 |
ACN
|
Joel Unruch
General Counsel/Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 90 Added 0.38% |
$20,114
$223.49 p/Share
|
Oct 05
2020 |
CFB
|
David L. O'Toole
CHIEF INVESTMENT OFFICER |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 3.09% |
$9,500
$9.5 p/Share
|
Oct 05
2020 |
MRNA
|
Tal Zvi Zaks
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$1,058,100
$70.54 p/Share
|
Oct 05
2020 |
MRNA
|
Tal Zvi Zaks
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 15,000 Added 50.0% |
$235,200
$15.68 p/Share
|
Oct 05
2020 |
CUE
|
Anish Suri
PRESIDENT AND CSO |
SELL
Payment of exercise price or tax liability
|
Direct | 9,800 Reduced 14.43% |
$159,740
$16.3 p/Share
|
Oct 05
2020 |
HGBL
|
Topline Capital Partners, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 27,708 Added 0.63% |
$51,537
$1.86 p/Share
|
Oct 05
2020 |
HGBL
|
Topline Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect | 27,708 Added 0.63% |
$51,537
$1.86 p/Share
|
Oct 05
2020 |
JSD
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,701 Added 0.14% |
$21,211
$12.47 p/Share
|
Oct 05
2020 |
JRO
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 128,002 Added 2.77% |
$1,063,697
$8.31 p/Share
|
Oct 05
2020 |
TIPT
|
Michael Gene Barnes
Executive Chairman |
BUY
Open market or private purchase
|
Direct | 2,852 Added 0.03% |
$14,203
$4.98 p/Share
|
Oct 05
2020 |
LQDT
|
William P Angrick Iii
Chairman of the Board and CEO |
BUY
Open market or private purchase
|
Indirect | 49,194 Added 0.9% |
$389,125
$7.91 p/Share
|
Oct 05
2020 |
CSTL
|
David S Kabakoff
Director |
SELL
Open market or private sale
|
Indirect | 25,000 Reduced 2.48% |
$1,302,250
$52.09 p/Share
|
Oct 05
2020 |
IESC
|
Jeffrey L Et Al Gendell
Executive Chairman |
BUY
Grant, award, or other acquisition
|
Indirect | 380 Added 0.0% |
-
|
Oct 05
2020 |
GBX
|
Mark J Rittenbaum
EVP, Chief Comm & Leasing Off |
SELL
Open market or private sale
|
Direct | 4,067 Reduced 6.58% |
$132,055
$32.47 p/Share
|
Oct 05
2020 |
CARG
|
Langley Steinert
Executive Chair |
SELL
Open market or private sale
|
Indirect | 987 Reduced 0.9% |
$22,178
$22.47 p/Share
|
Oct 05
2020 |
CARG
|
Langley Steinert
Executive Chair |
SELL
Open market or private sale
|
Direct | 12,006 Reduced 1.25% |
$269,775
$22.47 p/Share
|
Oct 05
2020 |
CARG
|
Thomas Michael Caputo
Chief Product Officer |
SELL
Open market or private sale
|
Direct | 3,443 Reduced 1.62% |
$77,295
$22.45 p/Share
|
Oct 05
2020 |
SMPL
|
David W Ritterbush
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,079 Added 50.0% |
-
|
Oct 05
2020 |
AQUA
|
Ronald C Keating
President and CEO |
SELL
Open market or private sale
|
Direct | 399,793 Reduced 46.2% |
$8,823,431
$22.07 p/Share
|
Oct 05
2020 |
AQUA
|
Ronald C Keating
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 399,793 Added 31.6% |
$1,855,039
$4.64 p/Share
|
Oct 05
2020 |
AQUA
|
Benedict J. Stas
EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct | 151,394 Reduced 45.65% |
$3,344,293
$22.09 p/Share
|
Oct 05
2020 |
AQUA
|
Benedict J. Stas
EVP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct | 151,394 Added 31.34% |
$702,468
$4.64 p/Share
|
Oct 05
2020 |
COLM
|
Sarah Bany
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 11,200 Reduced 0.17% |
$1,008,672
$90.06 p/Share
|
Oct 05
2020 |
BJ
|
Christopher J Baldwin
Director |
SELL
Open market or private sale
|
Direct | 265,562 Reduced 45.27% |
$10,845,552
$40.84 p/Share
|
Oct 05
2020 |
BJ
|
Christopher J Baldwin
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 265,562 Added 31.16% |
$4,514,554
$17.0 p/Share
|
Oct 05
2020 |
MORN
|
Joseph D Mansueto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 12,783 Reduced 0.06% |
$2,096,156
$163.98 p/Share
|
Oct 05
2020 |
XYL
|
Markos I Tambakeras |
SELL
Open market or private sale
|
Indirect | 6,050 Reduced 14.29% |
$515,642
$85.23 p/Share
|
Oct 05
2020 |
TDOC
|
Andrew Turitz
EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct | 1,389 Reduced 25.7% |
$308,997
$222.46 p/Share
|
Oct 05
2020 |
TDOC
|
Andrew Turitz
EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct | 1,389 Added 20.45% |
$30,975
$22.3 p/Share
|
Oct 05
2020 |
THRY
|
Goldentree Asset Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 5,005 Reduced 0.11% |
$73,073
$14.6 p/Share
|
Oct 05
2020 |
RMO
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 375,100 Reduced 14.46% |
$4,039,827
$10.77 p/Share
|
Oct 05
2020 |
FNF
|
Raymond R Quirk
Executive Vice-Chairman |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 11.83% |
$1,683,500
$33.67 p/Share
|
Oct 05
2020 |
FNF
|
Raymond R Quirk
Executive Vice-Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 50,000 Added 10.58% |
$888,000
$17.76 p/Share
|
Oct 05
2020 |
MRNA
|
Stephen Hoge
President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.52% |
$695,000
$69.5 p/Share
|
Oct 05
2020 |
MRNA
|
Stephen Hoge
President |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 0.51% |
$9,900
$0.99 p/Share
|
Oct 05
2020 |
TSN
|
Noel W White
Director |
BUY
Grant, award, or other acquisition
|
Direct | 13,559 Added 8.95% |
-
|
Oct 05
2020 |
REGN
|
Marion Mc Court
EVP Commercial |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 6.68% |
$600,000
$600.0 p/Share
|
Oct 05
2020 |
REGN
|
Marion Mc Court
EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct | 1,000 Added 6.26% |
$342,930
$342.93 p/Share
|
Oct 05
2020 |
CHRD
|
Thomas B Nusz
CEO |
SELL
Open market or private sale
|
Indirect | 98,607 Reduced 100.0% |
$17,749
$0.18 p/Share
|
Oct 05
2020 |
GTE
|
Rodger Derrick Trimble
VP, Investor Relations |
BUY
Grant, award, or other acquisition
|
Direct | 6,496 Added 3.96% |
$1,494
$0.23 p/Share
|
Oct 05
2020 |
GTE
|
Ryan Ellson
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 9,202 Added 2.37% |
$2,116
$0.23 p/Share
|
Oct 05
2020 |
GTE
|
Gary Guidry
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 12,991 Added 0.36% |
$2,988
$0.23 p/Share
|
Oct 05
2020 |